Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Proteins. 2017 Mar 11;85(5):843–851. doi: 10.1002/prot.25238

Figure 3. Competition SPR analysis of peptide 1 binding to trimeric BG505 SOSIP.664.gp140.

Figure 3

(Left) Representative sensorgrams showing dose-dependent inhibition of trimeric BG505 SOSIP.664 binding to CD4IgG2 by peptide 1. (Middle) Dose response curve derived from suppression of BG505 SOSIP.664 – CD4IgG2 binding sensorgrams by peptide 1. (Right) Negative control scrambled peptide 3, showing no inhibition of BG505 SOSIP.664 binding to CD4IgG2 (n=2).